CancerLife, a Digital Health Company, With the Validation Institute, Announces Results of Its Phase 3 Trial That Raised EQ-5 Quality of Life (QOL) Scores by 14.3%
June 02, 2022 09:30 ET | CancerLife
PHILADELPHIA, June 02, 2022 (GLOBE NEWSWIRE) -- CancerLife, a digital therapeutics company with the Validation Institute, announced the results of its two-arm, fully randomized Phase 3 clinical...
GMILogo_Vertical-Gradient.png
Outpatient Oncology Infusion Market worth USD 162.4 Billion by 2030, Says Global Market Insights Inc.
May 23, 2022 05:15 ET | Global Market Insights Inc.
Selbyville, Delaware, May 23, 2022 (GLOBE NEWSWIRE) -- The outpatient oncology infusion market value is projected to reach USD 162.4 billion by 2030, according to a new research report by Global...
Global Oncology Sterile Injectables Market
Outlook on the Oncology Sterile Injectables Global Market to 2028 - Faster Drug Approvals from Various Regulatory Bodies are Driving Growth
May 06, 2022 04:23 ET | Research and Markets
Dublin, May 06, 2022 (GLOBE NEWSWIRE) -- The "Oncology Sterile Injectables Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to...
GMILogo_Vertical-Gradient.png
Radiotherapy Market revenue to cross USD 9.7 Billion by 2028, Says Global Market Insights Inc.
May 04, 2022 04:15 ET | Global Market Insights Inc.
Selbyville, Delaware, May 04, 2022 (GLOBE NEWSWIRE) -- The radiotherapy market value is expected to exceed USD 9.7 billion by 2028, according to a new research report by Global Market Insights Inc....
The PROPHETIC trial involves patients with Stage IV non-small cell lung cancer, small cell lung cancer or malignant melanoma, and seeks to determine who will or will not respond to various forms of immunotherapies.
Florida Cancer Specialists & Research Institute Participating in Global Clinical Trial Analyzing Patient Responsiveness to Immunotherapy Treatment
May 02, 2022 08:00 ET | Florida Cancer Specialists & Research Institute
Fort Myers, Florida, May 02, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute medical oncologist Ernesto Bustinza-Linares, MD is serving as a Principal Investigator in a...
22157.jpg
Global Immune Checkpoint Inhibitors Market to 2027 - Size, Share & Industry Trends Analysis Report
April 26, 2022 06:43 ET | Research and Markets
Dublin, April 26, 2022 (GLOBE NEWSWIRE) -- The "Global Immune Checkpoint Inhibitors Market Size, Share & Industry Trends Analysis Report By Application (Lung Cancer, Bladder Cancer, Melanoma,...
logo-alt.png
Global Lung Cancer Diagnostic Test Market is estimated to be US$ 4.07 billion by 2030 with a CAGR of 7.50% during the forecast period - By PMI
April 19, 2022 09:52 ET | PMI
Covina, April 19, 2022 (GLOBE NEWSWIRE) -- Lung cancer starts in the lungs and can spread to the lymph nodes or other body organs, including the brain. Cancer that has progressed to other organs can...
Coherus BioSciences, Inc. logo
Coherus and Junshi Biosciences Announce PD-1 Inhibitor Toripalimab Granted Orphan Drug Designation for Small Cell Lung Cancer in the United States
April 14, 2022 08:30 ET | Coherus BioSciences, Inc.
REDWOOD CITY, Calif., and SHANGHAI, China, April 14, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS) and Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”,...
researchdrivelogo.jpg
Global Interventional Oncology Market Expected to Generate a Revenue of $3,313.5 Million, Rising at a CAGR of 6.7% during the Analysis Timeframe from 2021 to 2028 [170-Pages] | Exclusively Available by Research Dive
March 23, 2022 09:01 ET | Research Dive
New York, USA, March 23, 2022 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global interventional oncology market is envisioned to generate a revenue of $3,313.5...
Dr. Raymond Osarogiagbon
Lung Cancer Foundation of America (LCFA) is excited to announce the appointment of Dr. Raymond Osarogiagbon to its Scientific Advisory Board
March 22, 2022 05:03 ET | Lung Cancer Foundation of America
Los Angeles, CA, March 22, 2022 (GLOBE NEWSWIRE) -- Lung Cancer Foundation of America (LCFA) is pleased to welcome oncologist/hematologist Dr. Raymond Osarogiagbon to its Scientific Advisory Board...